Missouri was active in the 2018 legislative session and passed several bills aimed at lowering healthcare costs by reducing prescription prices and improving their state insurance exchange. Governor Eric Greitens signed SB 982 which protects emergency room patients from facing surprise medical bills. HB 1617 will expand access to telehealth services for Medicaid enrollees and clarify the Medicaid payment policy for telehealth services. The bill specifies that the Medicaid program will reimburse providers for telehealth services if the providers can ensure that the services meet the same standard of care as those provided in person. Additionally, SB 826 modifies certain healthcare provisions, including allowing pharmacists to prescribe generically equivalent drugs and inform consumers of lower costs.
In the 2017 legislative session, Missouri introduced, but did not pass legislation that requires greater price transparency. In addition, Missouri has collected inpatient and outpatient charge and utilization data since 1993, although there is no consumer website available to facilitate comparisons between providers and facilities.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare.
LEGISLATION: The Database of State Laws Impacting Healthcare Cost and Quality (SLIHCQ), created by The Source on Healthcare Price & Competition and Catalyst for Payment Reform, catalogues state legislation governing price transparency, provider market power, provider payment, provider networks, and benefit design. The database also includes pharmaceutical legislation beginning in the 2017-2018 legislative session. *Note: Current legislative session bill updates are ongoing. Check back weekly for updates.
LITIGATION: The Source tracks major litigation and antitrust enforcement action by federal entities (FTC or DOJ), state attorney generals, and private parties in the main provider and insurer markets, particularly legal challenges of healthcare consolidation and anticompetitive contract provisions. Additionally, the database contains major pharmaceutical cases including legislation challenges and significant appellate cases.
Search the database across all jurisdictions on the State Overview page, or view and filter existing legislation or litigation on individual state pages. The database allows customized search and filter by keyword, status, and/or key issue category. *Multiple filter/selections enabled. Click here for User Guide.